CCT-367766
CAS No. 2229856-58-8
CCT-367766( CCT367766 | CCT 367766 )
Catalog No. M13570 CAS No. 2229856-58-8
CCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCCT-367766
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.
-
DescriptionCCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.
-
In VitroCCT367766 (50-1500 nM; 24 hours) demonstates the depletion of pirin protein as a?the time-dependent hook-effect in SK-OV-3 human ovarian cancer cells.CCT367766 (0.5-50 nM; 2 hours) demonstrates the concentration-dependent depletion of pirin protein after 2 h exposure in SK-OV-3 cells.CCT367766 (0.5-50 nM; 2 hours) dose-dependently rescuses pirin expression from pretreatment of chlorobisamide in SK-OV-3 cells.Western Blot AnalysisCell Line:SK-OV-3 human ovarian cancer cells Concentration:50, 150, 250, 500 and 1500 nMIncubation Time:2 hours, 4 hours, 24 hours Result:Decreased pirin protein expression.Western Blot Analysis Cell Line:SK-OV-3 human ovarian cancer cells Concentration:0.5, 1, 2.5, 5, 7.5, 10, 25, and 50 nM Incubation Time:2 hours Result:Completely degraded pirin just at50 nM treatment.
-
In Vivo——
-
SynonymsCCT367766 | CCT 367766
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPROTAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2229856-58-8
-
Formula Weight946.41
-
Molecular FormulaC49H48ClN7O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC=C2N=C(CN3CCN(CCOCCOCCOC4=CC=CC(C(N5C(CC6)C(NC6=O)=O)=O)=C4C5=O)CC3)C=CC2=C1)NC7=CC(NC(C8=CC=C9OCCOC9=C8)=O)=CC=C7Cl
-
Chemical NameN-(2-Chloro-5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)phenyl)-2-((4-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)methyl)quinoline-6-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chessum NEA, et al. J Med Chem. 2017 Dec 14. doi: 10.1021/acs.jmedchem.7b01406.
molnova catalog
related products
-
TL13-12
TL13-12 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of TAE684 and the cereblon ligand pomalidomide.
-
Hydroxy-PEG5-Boc
Hydroxy-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Gefitinib-based PROT...
Gefitinib-based PROTAC 3 is a VHL-recruiting PROTAC that induces the degradation of EGFR and EGFR mutants with DC50 of 11.7 nM and 22.3 nM for HCC827 cell (Exon 19 del) and H3255 cell (L858R).
Cart
sales@molnova.com